ALRT.F Stock Overview
A data management company, provides diabetes care management solutions for human and animal health diabetes.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ALR Technologies SG Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.018 |
| 52 Week High | US$0.045 |
| 52 Week Low | US$0.0053 |
| Beta | 0.26 |
| 11 Month Change | 20.00% |
| 3 Month Change | 80.00% |
| 1 Year Change | -34.55% |
| 33 Year Change | -69.75% |
| 5 Year Change | -47.98% |
| Change since IPO | -80.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALRT.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 44.0% | -0.6% | 0.9% |
| 1Y | -34.5% | 20.8% | 32.3% |
Return vs Industry: ALRT.F underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: ALRT.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| ALRT.F volatility | |
|---|---|
| ALRT.F Average Weekly Movement | 70.7% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ALRT.F's share price has been volatile over the past 3 months.
Volatility Over Time: ALRT.F's weekly volatility has increased from 46% to 71% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 7 | Sidney S. Chan | www.alrt.com |
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions for human and animal health diabetes. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to assist veterinarians determine the efficacy of insulin treatments and to help to identify the appropriate dose and frequency of administration for companion animals.
ALR Technologies SG Ltd. Fundamentals Summary
| ALRT.F fundamental statistics | |
|---|---|
| Market cap | US$11.38m |
| Earnings (TTM) | -US$7.47m |
| Revenue (TTM) | US$25.54k |
445.8x
P/S Ratio-1.5x
P/E RatioIs ALRT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALRT.F income statement (TTM) | |
|---|---|
| Revenue | US$25.54k |
| Cost of Revenue | US$22.10k |
| Gross Profit | US$3.44k |
| Other Expenses | US$7.48m |
| Earnings | -US$7.47m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 13.47% |
| Net Profit Margin | -29,270.50% |
| Debt/Equity Ratio | -79.6% |
How did ALRT.F perform over the long term?
See historical performance and comparison